TBI-4000

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTBI-4000
Drug Alias Namevaccine adjuvant (Taiga Biotechnologies)TBI-4000
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsVaccination
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiga Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiga Biotechnologies Inc
Active IndicationsN/A
Inactive IndicationsVaccination

Other Information

ATC CodeN/A
Related LinksN/A